Steroid induced myopathy prognosis

Transdermal patches (adhesive patches placed on the skin) may also be used to deliver a steady dose through the skin and into the bloodstream. Testosterone-containing creams and gels that are applied daily to the skin are also available, but absorption is inefficient (roughly 10%, varying between individuals) and these treatments tend to be more expensive. Individuals who are especially physically active and/or bathe often may not be good candidates, since the medication can be washed off and may take up to six hours to be fully absorbed. There is also the risk that an intimate partner or child may come in contact with the application site and inadvertently dose himself or herself; children and women are highly sensitive to testosterone and can suffer unintended masculinization and health effects, even from small doses. Injection is the most common method used by individuals administering AAS for non-medical purposes. [45]

For patients who present with rhabdomyolysis, treatment is aimed at preventing kidney failure in the acute setting. Vigorous hydration with close monitoring of kidney function and electrolytes are paramount. In patients with an underlying metabolic myopathy, education about following a more moderate exercise program and avoiding intense exercise and fasting is necessary in preventing recurrent episodes. Measures that have been suggested to be helpful include sucrose loading before exercise in some glycogen storage disorders and a low-fat, high-carbohydrate diet in patients with lipid storage disorders.

Acute gout attacks can be managed with nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids (intra-articular injection or systemic). All three agents are appropriate first-line therapy for acute gout. Therapy should be initiated within 24 hours of onset. The drug selection is dictated by the patient's tolerance of those medications and the presence of any comorbid diseases that contraindicates the use of a specific drug. For patients with severe or refractory gout attacks, practitioners can try combining agents. If all of these medications are contraindicated in a patient, narcotics may be used short term to relieve pain until the acute attack has resolved. Long-term use of narcotics should be avoided.

Although the precise incidence is unknown, drug-induced myopathy is among the most common causes of muscle disease. Drug-induced myopathy ranges from mild myalgias with or without mild weakness to chronic myopathy with severe weakness and to massive rhabdomyolysis with acute renal failure [ 1,2 ]. Over 150 agents have been associated with rhabdomyolysis [ 3 ]. This topic will review drug-induced myopathies. Rhabdomyolysis and statin myopathy are discussed in detail separately. (See "Causes of rhabdomyolysis" and "Clinical manifestations and diagnosis of rhabdomyolysis" and "Statin myopathy" .)

Steroid induced myopathy prognosis

steroid induced myopathy prognosis

Although the precise incidence is unknown, drug-induced myopathy is among the most common causes of muscle disease. Drug-induced myopathy ranges from mild myalgias with or without mild weakness to chronic myopathy with severe weakness and to massive rhabdomyolysis with acute renal failure [ 1,2 ]. Over 150 agents have been associated with rhabdomyolysis [ 3 ]. This topic will review drug-induced myopathies. Rhabdomyolysis and statin myopathy are discussed in detail separately. (See "Causes of rhabdomyolysis" and "Clinical manifestations and diagnosis of rhabdomyolysis" and "Statin myopathy" .)

Media:

steroid induced myopathy prognosissteroid induced myopathy prognosissteroid induced myopathy prognosissteroid induced myopathy prognosissteroid induced myopathy prognosis

http://buy-steroids.org